NO20006701L - Kimkrystaller for fremstilling av peptider eller proteiner - Google Patents
Kimkrystaller for fremstilling av peptider eller proteinerInfo
- Publication number
- NO20006701L NO20006701L NO20006701A NO20006701A NO20006701L NO 20006701 L NO20006701 L NO 20006701L NO 20006701 A NO20006701 A NO 20006701A NO 20006701 A NO20006701 A NO 20006701A NO 20006701 L NO20006701 L NO 20006701L
- Authority
- NO
- Norway
- Prior art keywords
- insulin
- preparation
- microcrystals
- proteins
- peptides
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 239000013078 crystal Substances 0.000 title 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 10
- 102000004877 Insulin Human genes 0.000 abstract 5
- 108090001061 Insulin Proteins 0.000 abstract 5
- 229940125396 insulin Drugs 0.000 abstract 5
- 239000013081 microcrystal Substances 0.000 abstract 5
- 101000976075 Homo sapiens Insulin Proteins 0.000 abstract 3
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 239000000725 suspension Substances 0.000 abstract 3
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 abstract 1
- 102400000321 Glucagon Human genes 0.000 abstract 1
- 108060003199 Glucagon Proteins 0.000 abstract 1
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 abstract 1
- 102100040918 Pro-glucagon Human genes 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 abstract 1
- 229960004666 glucagon Drugs 0.000 abstract 1
- 239000000122 growth hormone Substances 0.000 abstract 1
- 238000000265 homogenisation Methods 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
- C30B29/54—Organic compounds
- C30B29/58—Macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Metallurgy (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Fremgangsmåte for fremstilling av kimmikrokrystaller for fremstillingen av humaninsulin, hvor mikrokrystallene er fri for ikke-humant, pankreatisk insulin, idet fremgangsmåten omfatter til-veiebringelse av en ikke-kimbehandlet suspensjon av humaninsulin, hvor suspen-sjonen er fri for ikke-humant, pankreatisk insulin, og insulinsuspensjonen homogeniseres under trykk slik at det fås humaninsulinmikrokrystaller som er egnet for anvendelse som kimmikrokrystaller for fremstillingen av sinkinsu-linprodukter. Fremgangsmåten for homo-genisering under trykk kan også brukes til fremstillingen av kimmikrokrystaller for andre peptider og proteiner, særlig farmasøytiske peptider eller proteiner, slik som insulin, GLP-1, glukagon og veksthormoner.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98610020 | 1998-06-30 | ||
US9288298P | 1998-07-15 | 1998-07-15 | |
PCT/DK1999/000371 WO2000001727A1 (en) | 1998-06-30 | 1999-06-30 | Seeding crystals for the preparation of peptides or proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20006701L true NO20006701L (no) | 2000-12-29 |
NO20006701D0 NO20006701D0 (no) | 2000-12-29 |
Family
ID=26151840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20006701A NO20006701D0 (no) | 1998-06-30 | 2000-12-29 | Kimkrystaller for fremstilling av peptider eller proteiner |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1091979B1 (no) |
JP (1) | JP2002519437A (no) |
KR (1) | KR20010071666A (no) |
CN (1) | CN1307589A (no) |
AT (1) | ATE340189T1 (no) |
AU (1) | AU758496B2 (no) |
BR (1) | BR9911678A (no) |
CA (1) | CA2336112A1 (no) |
DE (1) | DE69933296T2 (no) |
ES (1) | ES2273501T3 (no) |
HU (1) | HUP0102577A3 (no) |
IL (1) | IL140341A0 (no) |
NO (1) | NO20006701D0 (no) |
PL (1) | PL345260A1 (no) |
WO (1) | WO2000001727A1 (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1351984A2 (en) | 2000-12-13 | 2003-10-15 | Eli Lilly And Company | Amidated glucagon-like peptide-1 |
DK1463751T3 (da) | 2001-12-21 | 2013-08-26 | Human Genome Sciences Inc | Albuminfusionsproteiner. |
EP2158927A1 (en) * | 2008-08-25 | 2010-03-03 | Debiotech S.A. | Drug delivery device with a module for preventing fibrillation downstream of its reservoir |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB766994A (en) * | 1953-11-13 | 1957-01-30 | Novo Terapeutisk Labortorium A | Improved process in crystallization of insulin |
GB766995A (en) * | 1953-11-14 | 1957-01-30 | Novo Terapeutisk Labor As | Improvements in or relating to the production of insulin crystals |
FR2527903A1 (fr) * | 1982-06-03 | 1983-12-09 | Noelle Ancenis Coop Agricole | Procede et installation pour l'obtention d'un produit gras en tout point comparable au beurre |
WO1988002633A1 (en) * | 1986-10-20 | 1988-04-21 | Novo Industri A/S | Protamine zinc insulin preparations |
BR8803345A (pt) * | 1988-06-30 | 1990-02-13 | Biobras Bioquimica Do Brasil S | Processo aperfeicoado para producao em larga escala de cristais de insulina humana purificada |
JP2554784B2 (ja) * | 1991-03-15 | 1996-11-13 | 杏林製薬株式会社 | 懸濁シロップ剤 |
NL9201408A (nl) * | 1992-08-05 | 1994-03-01 | Holland Sweetener Co | Werkwijze voor het kristalliseren van aspartaam. |
-
1999
- 1999-06-30 BR BR9911678-2A patent/BR9911678A/pt not_active IP Right Cessation
- 1999-06-30 CN CN99807953A patent/CN1307589A/zh active Pending
- 1999-06-30 CA CA002336112A patent/CA2336112A1/en not_active Abandoned
- 1999-06-30 PL PL99345260A patent/PL345260A1/xx not_active Application Discontinuation
- 1999-06-30 HU HU0102577A patent/HUP0102577A3/hu unknown
- 1999-06-30 KR KR1020007014921A patent/KR20010071666A/ko not_active Application Discontinuation
- 1999-06-30 JP JP2000558128A patent/JP2002519437A/ja active Pending
- 1999-06-30 AU AU47685/99A patent/AU758496B2/en not_active Ceased
- 1999-06-30 EP EP99931016A patent/EP1091979B1/en not_active Expired - Lifetime
- 1999-06-30 ES ES99931016T patent/ES2273501T3/es not_active Expired - Lifetime
- 1999-06-30 WO PCT/DK1999/000371 patent/WO2000001727A1/en not_active Application Discontinuation
- 1999-06-30 AT AT99931016T patent/ATE340189T1/de not_active IP Right Cessation
- 1999-06-30 DE DE69933296T patent/DE69933296T2/de not_active Expired - Lifetime
- 1999-06-30 IL IL14034199A patent/IL140341A0/xx unknown
-
2000
- 2000-12-29 NO NO20006701A patent/NO20006701D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU758496B2 (en) | 2003-03-20 |
KR20010071666A (ko) | 2001-07-31 |
BR9911678A (pt) | 2001-03-20 |
JP2002519437A (ja) | 2002-07-02 |
HUP0102577A2 (hu) | 2002-01-28 |
ATE340189T1 (de) | 2006-10-15 |
CA2336112A1 (en) | 2000-01-13 |
IL140341A0 (en) | 2002-02-10 |
CN1307589A (zh) | 2001-08-08 |
NO20006701D0 (no) | 2000-12-29 |
EP1091979B1 (en) | 2006-09-20 |
PL345260A1 (en) | 2001-12-03 |
DE69933296D1 (de) | 2006-11-02 |
ES2273501T3 (es) | 2007-05-01 |
DE69933296T2 (de) | 2007-05-03 |
EP1091979A1 (en) | 2001-04-18 |
WO2000001727A1 (en) | 2000-01-13 |
AU4768599A (en) | 2000-01-24 |
HUP0102577A3 (en) | 2002-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Stegwee et al. | Hormonal control of reversible degeneration of flight muscle in the Colorado potato beetle, Leptinotarsa decemlineata Say (Coleoptera) | |
Nakanishi et al. | Biosynthesis of α and β-ecdysones from cholesterol outside the prothoracic gland in Bombyx mori | |
ATE110745T1 (de) | Wachstumshormonkristalle und verfahren zu deren herstellung. | |
HU9501953D0 (en) | Pharmaceutically active pyridine derivatives and process for the preparation thereof | |
HUT44793A (en) | Process for production of 19-nor or 19-nor-d-homo stereoids substituated in position 11-beta by alkinylphenil group and medical preparatives containing them as active substance | |
MY129581A (en) | New 3-aryl propionic acid derivatives and analogs | |
DK280884A (da) | Galeniske praeparatformer for orale antidiabetica og fremgangsmaade til deres fremstilling | |
HUT51865A (en) | Herbicides containing as active substance derivatives of salycil acid or their sulfhur-analoges, further compositions regulating the growt of plants containing salycil acid derivatives and process for production of the active substances | |
Abeles et al. | Abscission: Role of protein synthesis | |
RU94029667A (ru) | ПРОИЗВОДНЫЕ 11β -БЕНЗАЛЬДОКСИМ-ЭСТРА-4,9-ДИЕНА, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ЛЕКАРСТВЕННЫЕ СРЕДСТВА | |
Ipp et al. | Vasoactive intestinal peptide stimulates pancreatic somatostatin release | |
NO20006701L (no) | Kimkrystaller for fremstilling av peptider eller proteiner | |
ATE17651T1 (de) | Mischung zum verabreichen bei menschen von selenium als spurenelement. | |
ATE459355T1 (de) | Verfahren zur behandlung von erkrankungen mit mangel an thiolhaltiger verbindung | |
ES2038605T3 (es) | Un metodo para la produccion de una preparacion de tipo no liquido para inyeccion. | |
ES2169188T3 (es) | Produccion de condimento. | |
HUT57204A (en) | Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them | |
Stumm et al. | Histone bei dem Phycomyceten Allomyces arbuscula (Butl.) | |
ATE113849T1 (de) | Verwendung von polysacchariden in zubereitungen zur wundbehandlung. | |
Donaldson et al. | Induced ovulation in coho salmon (Oncorhynchus kisutch). III. Preliminary study on the use of the antiestrogen tamoxifen | |
Sroka et al. | The timing of juvenile hormone release for ovarian maturation in Manduca sexta | |
KR920016026A (ko) | 인삼을 이용한 젤리의 제조방법 | |
AU1355492A (en) | Method for extracting a biological substance from lepidoptera larvas and substance thus obtained | |
CN100534441C (zh) | 一种水产养殖用苗种活力快速恢复剂 | |
UA19804A (uk) | Спосіб стимулюваhhя розумової діяльhості та спосіб діагhостики старечого hедоумства |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |